greater than controls by targeted immunoprecipitation of the epitope-containing peptide), at least 17% of sera from patients with MIS-C are autoreactive for SNX8; however, approximately 37% of sera from patients with MIS-C yielded detectable enrichment compared with controls in the entire dataset. The gene discussed is SNX8; the disease is COVID-19–associated multisystem inflammatory syndrome in children.